Lasco Distributors Limited will roll out 85 pharmaceutical products on the Jamaica market by yearend under an expanded partnership with Indian drug-maker Cipla Limited.
The partners will provide cardiovascular, diabetic, respiratory, oncology and urology, antibiotics and pain-management medication.
"What we are working on out of the partnership is more affordable drugs," said marketing manager for Lasco Pharmaceuticals, Tamara Simmonds.
"Right now, a lot of the LASMED and Cipla products are offered to National Health Fund and Drug Serv through tender pricing to the Government," she said.
She said the partnership is intended to introduce even more cost-effective drugs to the Jamaican market.
"There are very affordable generics out of India and it provides the Government an opportunity to give better pricing and (lower) the health bill for the patient," said Simmonds.
About 40 per cent of the generic drug market is held by the Lasco's pharmaceutical division, she said.
Roll-out of the 85 products will span October through to the end of the year with some items bearing the LASMED logo while others, such as the oncology products, will bear the Cipla brand, Simmonds said.
Cipla and Lasco have been partners for 13 years. Lasco touts one of the triumphs of the partnership as the 2006 introduction of antiretroviral drugs for persons with HIV/AIDS to the Jamaican market under the Global Fund Initiative.